Cisapride

"Cisapride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)

Descriptor ID

D020117

MeSH Number(s)

D02.065.277.135

D02.241.223.100.120.135

D03.383.621.135

Concept/Terms

Cisapride

Propulsid

R-51619

Below are MeSH descriptors whose meaning is more general than "Cisapride".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amides [D02.065]
Benzamides [D02.065.277]
Cisapride [D02.065.277.135]
Carboxylic Acids [D02.241]
Acids, Carbocyclic [D02.241.223]
Benzoic Acids [D02.241.223.100]
Benzamides [D02.241.223.100.120]
Cisapride [D02.241.223.100.120.135]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Piperidines [D03.383.621]
Cisapride [D03.383.621.135]

Below are MeSH descriptors whose meaning is more specific than "Cisapride".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cisapride" by people in Harvard Catalyst Profiles by year, and whether "Cisapride" was a major or minor topic of these publication.

Bar chart showing 15 publications over 7 distinct years, with a maximum of 4 publications in 2000

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	2	2
1998	0	2	2
1999	1	2	3
2000	3	1	4
2002	2	0	2
2011	1	0	1
2013	0	1	1

Below are the most recent publications written about "Cisapride" by people in Profiles.

Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One. 2013; 8(8):e72148.

View in: PubMed
Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility. J Pediatr Gastroenterol Nutr. 2011 May; 52(5):590-4.

View in: PubMed
A distributed, collaborative intelligent agent system approach for proactive postmarketing drug safety surveillance. IEEE Trans Inf Technol Biomed. 2010 May; 14(3):826-37.

View in: PubMed
Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay. J Cardiovasc Pharmacol. 2007 May; 49(5):269-74.

View in: PubMed
[The diverse etiology of hiccups]. Harefuah. 2003 Jan; 142(1):10-3, 79.

View in: PubMed
The impact of wording in "Dear doctor" letters and in black box labels. Clin Pharmacol Ther. 2002 Dec; 72(6):735-42.

View in: PubMed
Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf. 2002 Sep; 11(6):477-86.

View in: PubMed
Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA. 2000 Dec 20; 284(23):3036-9.

View in: PubMed
Advances in the management of pediatric constipation. Curr Gastroenterol Rep. 2000 Jun; 2(3):234-40.

View in: PubMed
The efficacy of cisapride: what is needed for digestion? J Pediatr Gastroenterol Nutr. 2000 Mar; 30(3):230-1.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Pediatr Gastroenterol Nutr
Pharmacoepidemiol Drug Saf
JAMA
J Pediatr
Clin Pharmacol Ther
IEEE Trans Inf Technol Biomed
Harefuah
Curr Gastroenterol Rep
Can J Gastroenterol
Am J Physiol